Table 2. Comparison of baseline characteristics between non-hyperuricemic and hyperuricemic subjects.
| Non-hyperuricemia (n = 236) | Hyperuricemia (n = 24) | p-value | |
|---|---|---|---|
| Male (n = 142) | 130 (91.6%) | 12 (8.4%) | - |
| SUA (μmol/L) | 303 ± 65 (416) | 529 ±140 (826) | 0.000 |
| Female (n = 118) | 106 (89.8%) | 12 (10.2%) | - |
| SUA (μmol/L) | 246 ± 57 (357) | 390.7± 30.8 (440) | 0.000 |
| Age (years) | 32.5 ± 13.1 | 32.8 ± 15.3 | 0.910 |
| WC (cm) | 84.0 ± 8.6 | 90.7 ± 7.9 | 0.006 |
| HC(cm) | 93.3 ± 7.5 | 98.8 ± 8.9 | 0.011 |
| BMI (kg/m2) | 24.5 ± 3.8 | 26.9 ± 4.5 | 0.005 |
| TG (mg/dl) | 150.5 ± 92.2 | 162.6 ± 67.0 | 0.047 |
| TC (mg/dl) | 136.8 ± 49.6 | 162.1 ± 34.0 | 0.042 |
| HDL (mg/dl) | 47.3 ± 12.6 | 42.6 ± 10.9 | 0.045 |
| LDL (mg/dl) | 74.6 ± 39.2 | 88.1 ± 42.0 | 0.320 |
Values are presented as mean ± SD. SUA level indicated in parentheses as the maximum. Hyperurecmia was defined as the SUA level in men ≥416.4 (7mg/dl) and in women ≥356.9 (6mg/dl) by Sui et al. [30].